NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
VORWARTS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
11/12/2025
Trademark type
Combined
Nice classes
5
Filing date
02/13/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/01/2024
First use in commerce
02/01/2024
Drawing code
3
Owner type
16
Owner location
Riga, LV
Examiner
KEAM,ALEX S
Law office
O60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "VORWARTS PHARMA" written in stylized big black letters, where the letter "V" of the word "VORWARTS" is green and the letter "P" of the word "PHARMA" is grey, with the design of black line that is displayed under the verbal elements..
Holders and representatives
Holders
V. S. (pessoa física)
Representatives
Diana Portna
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Acai powder dietary supplements; Acaricides; Adjuvants for medical purposes; Albumin dietary supplements; Alginate dietary supplements; Amino acids for medical purposes; Anaesthetics; Analgesics; Anthelmintics; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antibiotics; Antiparasitic preparations; Antiseptics; Appetite suppressant pills; Bacterial preparations for medical and veterinary use; Bacteriological preparations for medical and veterinary use; Cardiovascular pharmaceuticals; Casein dietary supplements; Cellulose esters for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposesfor the treatment of erectile dysfunctionfor the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesfor the treatment of cardiovascular and cerebrovascular diseasesfor the treatment of anaphylactic reactions;; Dietary supplements with a cosmetic effect; Digestives for pharmaceutical purposes; Enzyme dietary supplements; Enzyme preparations for medical purposes; Ferments for pharmaceutical purposes; Food supplementsanti-oxidants; Glycerine for medical purposes; Haemoglobin; Herbal extractsother than essential oilsfor medical purposes; Infant formula; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Lecithin dietary supplements; Medical preparations for slimming purposes; Medicated candies; Medicinal preparations for the treatment of erectile dysfunctionfor the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesfor the treatment of cardiovascular and cerebrovascular diseasesfor the treatment of anaphylactic reactions; Mineral dietary supplements; Nutraceuticals for the treatment of erectile dysfunctionocular disorders or diseasesbacteria-based diseasesdiabetescardiovascular and cerebrovascular diseasesanaphylactic reactions; Nutraceuticals for use as a dietary supplement; Nutritional supplements; Ocular pharmaceuticals; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of rectile dysfunctionocular disorders or diseasesbacteria-based diseasesdiabetescardiovascular and cerebrovascular diseasesanaphylactic reactions; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsanti-infectives; Pharmaceuticalsantihelmintics; Pharmaceuticalsinducers of erections; Pharmaceuticalslipid lowering agents; Pharmaceuticalspsychotropics; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis dietary supplements; Propolis for pharmaceutical purposes; Protein dietary supplements; Vaginal washes for medical purposes; Vermifuges; Vitamin preparations; Wheat germ dietary supplements; Yeast dietary supplements; Yeast for pharmaceutical purposes
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/21/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/18/2025
IUAF
USE AMENDMENT FILED
05/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/15/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2024
DOCK
ASSIGNED TO EXAMINER
10/02/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/25/2024
NWAP
NEW APPLICATION ENTERED
02/13/2024
Continuous trademark protection
Get notified about every new filing that threatens VORWARTS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.